Page 3 - அளவுகோல்கள் சைக்சா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அளவுகோல்கள் சைக்சா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அளவுகோல்கள் சைக்சா Today - Breaking & Trending Today

El CEO de Criteria Caixa abandona el consejo de Naturgy en plena OPA

El CEO de Criteria Caixa abandona el consejo de Naturgy en plena OPA
elplural.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elplural.com Daily Mail and Mail on Sunday newspapers.

Criteria Caixa , Naturgy Criteria , Takeover Bid , அளவுகோல்கள் சைக்சா , கையகப்படுத்தல் ஏலம் ,

Marcelino Armenter, CEO de Criteria, deja el consejo de Naturgy en plena opa | Compañías

Marcelino Armenter, CEO de Criteria, deja el consejo de Naturgy en plena opa | Compañías
elpais.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elpais.com Daily Mail and Mail on Sunday newspapers.

Criteria Caixa , Green Light , அளவுகோல்கள் சைக்சா , பச்சை ஒளி ,

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman


Share this article
Share this article
MADRID, Feb. 10, 2021 /PRNewswire/ MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II. Having achieved pre-clinical feasibility in 2020, these proceeds will now enable MedLumics to initiate first in-human regulatory clinical studie ....

Comunidad Autonoma De Cataluna , Comunidad Autonoma De Aragon , Olivier Litzka , Prnewswire Medlumics , James Greene , Peter Neubeck , Kurma Biofund , University Of South Florida , Medlumics Ireland Ltd , Sabadell Asabys Health Innovation Investments , European Fund For Strategic Investments , Its Life Sciences , Stanford Biodesign Emerging Entrepreneurs Forum , Stanford Coulter Foundation For Translational Medicine , Ashland University , European Union , Life Sciences , Vi Partners Swiss Innovation Fund , Atrial Fibrillation , Erich Ferrari , Asabys Partners , Swiss Innovation , Andera Partners , Caixa Capital Risc , Innogest Capital , Managing Director ,

Fitch revisará el rating de Naturgy si IFM y los fondos pactan dar más dividendos

Fitch revisará el rating de Naturgy si IFM y los fondos pactan dar más dividendos
eleconomista.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eleconomista.es Daily Mail and Mail on Sunday newspapers.

Agency Fitch , Fitch Will , Criteria Fitch , Criteria Caixa , Impala Terminals , Facebook Twitter , அளவுகோல்கள் சைக்சா , இம்பழ முனையங்கள் , முகநூல் ட்விட்டர் ,